Cargando…

Renal cell carcinoma with central nervous system demyelination caused by nivolumab

INTRODUCTION: Central nervous system demyelination caused by immune checkpoint inhibitors is a very rare condition. CASE PRESENTATION: A 65‐year‐old man who received nivolumab for renal cell carcinoma developed abnormal behavior, such as disagreeable speech and sudden anger. Brain‐enhanced magnetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oka, Toshiki, Yamamoto, Yoshiyuki, Okuda, Yohei, Asakura, Toshihisa, Hatano, Koji, Nakai, Yasutomo, Nakayama, Masashi, Kakimoto, Ken‐ichi, Sugai, Fuminobu, Nishimura, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784733/ https://www.ncbi.nlm.nih.gov/pubmed/33426497 http://dx.doi.org/10.1002/iju5.12234

Ejemplares similares

Partial nephrectomy for a Bosniak IV cystic renal mass mimicking a simple renal cyst adjacent to a solid renal tumor
por: Oka, Toshiki, et al.
Publicado: (2020)

Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
por: Nakai, Yasutomo, et al.
Publicado: (2021)

Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Yamamoto, Akinaru, et al.
Publicado: (2020)

Solitary fibrous tumor mimicking adrenal tumor concomitant with contralateral adrenal pheochromocytoma: A case report of surgical resection after long-term observation
por: Kuribayashi, Sohei, et al.
Publicado: (2019)

Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report
por: Yasui, Taku, et al.
Publicado: (2020)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient
por: Pillonel, Vincent, et al.
Publicado: (2019)

Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma
por: Bajagain, Madan, et al.
Publicado: (2020)

Central nervous system inflammatory demyelinating disorders of childhood
por: Kamate, Mahesh, et al.
Publicado: (2010)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

The Role of Extracellular Vesicles in Demyelination of the Central Nervous System
por: López-Guerrero, José Antonio, et al.
Publicado: (2020)

Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy
por: Kambayashi, Yumi, et al.
Publicado: (2020)

Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells
por: Hatano, Koji, et al.
Publicado: (2012)

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
por: Nishimura, Yuki, et al.
Publicado: (2022)

Editorial Comment on “Recurrent multiple liver metastases of clear cell renal cell carcinoma with a significant response to sunitinib after nivolumab treatment: A case report”
por: Hatano, Koji
Publicado: (2022)

Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy
por: Nakamura, Yoshiyuki, et al.
Publicado: (2021)

Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report
por: Park, Chulmin, et al.
Publicado: (2023)

IMMU-19. NIVOLUMAB-INDUCED CNS DEMYELINATION IN A 15-YEAR-OLD WITH CLASSIC HODGKIN LYMPHOMA
por: Ramirez, Alejandra, et al.
Publicado: (2023)

Comment on: Central nervous system inflammatory demyelinating disorders of childhood
por: Radhakrishna, H.
Publicado: (2011)

HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
por: Mariotto, Sara, et al.
Publicado: (2014)

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system
por: Gonzalez, Ginez A., et al.
Publicado: (2016)

Citation classics in central nervous system inflammatory demyelinating disease
por: Kim, Jee‐Eun, et al.
Publicado: (2017)

Coronavirus infects and causes demyelination in primate central nervous system
por: Murray, Ronald S., et al.
Publicado: (1992)

Demyelinating Disease of the Central Nervous System Concurrent With COVID-19
por: Karsidag, Sibel, et al.
Publicado: (2021)

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders
por: Patil, Varsha A., et al.
Publicado: (2021)

Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors
por: Kawahara, Takashi, et al.
Publicado: (2022)

Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination
por: Sharma, Rakhi, et al.
Publicado: (2010)

Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
por: Uemura, Toshihiro, et al.
Publicado: (2023)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Acquired demyelinating disorders of central nervous system: A pediatric cohort
por: Gulati, Sheffali, et al.
Publicado: (2015)

The crucial role of Erk2 in demyelinating inflammation in the central nervous system
por: Okazaki, Rentaro, et al.
Publicado: (2016)

Imaging Central Nervous System Demyelination and Remyelination by Positron-Emission Tomography
por: Bodini, Benedetta, et al.
Publicado: (2016)

Insights into Initial Demyelinating Episodes of Central Nervous System during Puerperium
por: Wu, Qian, et al.
Publicado: (2017)

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
por: Qiu, Ke, et al.
Publicado: (2019)

Central nervous system demyelinating diseases: glial cells at the hub of pathology
por: Coutinho Costa, Vinicius Gabriel, et al.
Publicado: (2023)

Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
por: Ishido, Hideaki, et al.
Publicado: (2023)

Sonographic Multifocal Cranial Nerve Enlargement in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy
por: Oka, Yuwa, et al.
Publicado: (2021)

Refractory hypotension due to Nivolumab-induced adrenal insufficiency
por: Tsukizawa, Yoshiaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ks8redvir5tjee5adqghfejdvp